Form 4 Tracker
Dyne Therapeutics, Inc.
DYN

25 insider filings · Latest: May 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 22, 2024Nov 22 9:06 PMForbion Capital Fund IV Cooperatief U.A.
Proposed Sale
62,301$30.00$1.9M

View →

Nov 18, 2024Nov 18 9:40 PMIncerti Carlo
Proposed Sale
16,500$28.00$462.0K

View →

Nov 18, 2024Nov 18 9:13 PMFarwell Wildon
Proposed Sale
2,515$28.39$71.4K

View →

Nov 18, 2024Nov 18 9:10 PMScalzo Richard William
Proposed Sale
2,735$28.39$77.6K

View →

Nov 18, 2024Nov 18 9:06 PMBeskrovnaya Oxana
Proposed Sale
2,856$28.39$81.1K

View →

Nov 18, 2024Nov 18 9:05 PMMcNeill Jonathan
Proposed Sale
2,658$28.39$75.5K

View →

Nov 18, 2024Nov 18 9:04 PMHIGH SUSANNA GATTI
Proposed Sale
2,892$28.39$82.1K

View →

Nov 14, 2024Nov 14 9:59 PMForDyne B.V.
Proposed Sale
1,500,000$32.83$49.3M

View →

Sep 18, 2024Sep 18 8:24 PMScalzo Richard William
Proposed Sale
1,390$34.51$48.0K

View →

Sep 18, 2024Sep 18 8:23 PMBeskrovnaya Oxana
Proposed Sale
2,339$34.51$80.7K

View →

Sep 18, 2024Sep 18 8:21 PMMcNeill Jonathan
Proposed Sale
1,870$34.51$64.5K

View →

Sep 18, 2024Sep 18 8:20 PMHIGH SUSANNA GATTI
Proposed Sale
8,967$34.41$308.5K

View →

Sep 11, 2024Sep 11 8:36 PMFarwell Wildon
Proposed Sale
2,645$32.43$85.8K

View →

Sep 11, 2024Sep 11 8:34 PMHIGH SUSANNA GATTI
Proposed Sale
5,270$32.43$170.9K

View →

Sep 11, 2024Sep 11 8:31 PMScalzo Richard William
Proposed Sale
1,468$32.43$47.6K

View →

Sep 11, 2024Sep 11 8:28 PMBeskrovnaya Oxana
Proposed Sale
2,161$32.43$70.1K

View →

Sep 11, 2024Sep 11 8:26 PMMcNeill Jonathan
Proposed Sale
1,823$32.43$59.1K

View →

Aug 19, 2024Sep 6 8:22 PMScalzo Richard William
Proposed Sale
126,073$33.65$4.2M

View →

Sep 5, 2024Sep 5 8:34 PMMcNeill Jonathan
Proposed Sale
166,767$33.61$5.6M

View →

← Previous

Page 6 of 6

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 12, 2026Feb 17 10:11 PMJohn CoxDirector, CEO & President
Grant/Award
285,000$16.00285,000(D)

View →

Feb 12, 2026Feb 17 10:10 PMDouglas KerrChief Medical Officer
Grant/Award
130,000$16.00130,000(D)

View →

Feb 12, 2026Feb 17 10:09 PMJohanna Friedl-NadererChief Commercial Officer
Grant/Award
90,000$16.0090,000(D)

View →

Feb 12, 2026Feb 17 10:08 PMErick LuceraChief Financial Officer
Grant/Award
105,000$16.00105,000(D)

View →